Compare Becton Dickinson and Co (BDX) vs Home Depot Inc (HD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs Home Depot Inc — how do they compare? Becton Dickinson and Co trades at $154.99 (market cap $41.51B), while Home Depot Inc trades at $341.45 (market cap $336.77B). The key difference: Home Depot Inc is far larger — about 8.1× Becton Dickinson and Co's market cap, and Becton Dickinson and Co pays the higher dividend (2.79%). Which is the better fit depends on your goals.
| BDX | HD | |
|---|---|---|
Market Cap | $41.51B | $336.77B |
Sector | Health | Consumer Cyclical |
52-Week High | $185.39 | $423.42 |
52-Week Low | $135.49 | $297.51 |
Enterprise Value | $57.97B | $398.32B |
Dividend Yield | 2.79% | 2.76% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BDX trades at $153.83, up 1.24% today, with technical indicators showing a neutral to bullish bias. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $2.90 exceeding expectations. Revenue growth remains steady, reaching $21.84B in 2025, though net margins have compressed to 5.12%. Recent news highlights BDX's innovation in medical technology and positive analyst sentiment.
The outlook for BDX appears balanced. Upside potential exists from continued earnings beats and strategic positioning in growing healthcare segments like GLP-1 drug support equipment. However, risks include margin pressure, elevated debt levels, and cautious hospital spending. The consensus price target of $173.40 suggests moderate upside from current levels.
Home Depot (HD) trades at $341.44, up 1.28% over 24 hours, with technical indicators showing a bearish bias despite recent earnings beats. The stock faces headwinds from weak big-ticket demand and margin pressures, though Pro segment growth and housing tailwinds provide support. Revenue reached $159.51B in 2025 with a net income margin of 8.41%, while valuation metrics like a P/E of 23.99 suggest moderate pricing relative to earnings.
The outlook is mixed: analyst consensus leans bullish with a $370.59 price target, but near-term risks include rising mortgage rates and competitive pressures. Long-term investors may find value in HD's resilient business model and dividend yield, though volatility from macroeconomic factors warrants caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About Home Depot Inc
Home Depot is the world's largest home improvement specialty retailer, operating more than 2,300 warehouse-format stores offering more than 30,000 products in store and 1 million products online in the United States, Canada, and Mexico. Its stores offer numerous building materials, home improvement products, lawn and garden products, and decor products and provide various services, including home improvement installation services and tool and equipment rentals. The acquisition of distributor Interline Brands in 2015 allowed Home Depot to enter the maintenance, repair, and operations business, which has been expanded through the tie-up with HD Supply (2020). The addition of the Company Store brought textile exposure to Home Depot's lineup.
Read more on HD →
